<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymph nodes or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biopsies of 60 persons suspected of having a malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were examined for the presence of Epstein-Barr virus nuclear antigen (EBNA) by anticomplement immunofluorescence </plain></SENT>
<SENT sid="1" pm="."><plain>In 8 cases the tissue specimens were also assayed for Epstein-Barr virus (EBV) DNA by nucleic acid hybridization </plain></SENT>
<SENT sid="2" pm="."><plain>Serum samples of patients and controls were tested for EBV-related antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>The histological tests in 37 cases showed a malignant non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and in 23 cases a reactive <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of a European boy and a polymorphic centroblastoma contained EBNA and approximately 27 or 30 genome equivalents EBV DNA per cell, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>EBNA was also demonstrated in about 20% of the cells of a lymph node from a patient with recurrent reactive <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> </plain></SENT>
</text></document>